Generation and Characterization of a New Preclinical Mouse Model of EGFR-Driven Lung Cancer with MET-Induced Osimertinib Resistance

SIMPLE SUMMARY: The use of targeted therapy has changed the clinical management of lung cancer patients, increasing both their life quality and expectancy. Conversely, the appearance of resistance occurs in almost all patients receiving this therapy. In this regard, new strategies combining differen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers (Basel)
Hauptverfasser: Mancini, Maicol, Thomas, Quentin-Dominique, Bourdel, Sylvia, Papon, Laura, Bousquet, Emilie, Jalta, Prisca, La Monica, Silvia, Travert, Camille, Alfieri, Roberta, Quantin, Xavier, Cañamero, Marta, Maraver, Antonio
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2021
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8307933/
https://ncbi.nlm.nih.gov/pubmed/34298655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13143441
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge